Eckert Group

You are here:

MRD - Minimal residual disease

Remaining leukemic cells that persist in the body of patients after treatment are called minimal residual disease (MRD). These cells are very hard to detect and are the major cause of relapses in these patients. It is believed that these cells were able to resist initial therapy by developing drug resistance(s).

MRD Diagnostics

Dr. Eckert's lab is in charge of the molecular genetics diagnostics laboratory for MRD diagnostic in Close collaboration with the current ALL-REZ BFM study conducted with the Pediatric Hematology and Oncology department at the Charité.